NASDAQ:OACC
Oaktree Acquisition Corp. III Life Sciences
Oaktree Acquisition Corp. III Life Sciences reported net income of $7.3M in fiscal 2025.Summary generated from Oaktree Acquisition Corp. III Life Sciences's SEC filings. Latest annual report filed Mar 26, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)n/a
Revenue growthn/a
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating marginn/a
Net marginn/a
ROICn/a
Return on equityn/a
Debt / equityn/a
Free cash flown/a
FCF marginn/a
Share count changen/a
Financials
| Item | 2025 |
|---|---|
| Revenue | n/a |
| Operating income | −1 |
| Net income | 7 |
| Free cash flow | n/a |
Recent filings
- DEF 14AProxy statement
Oct 2, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 12, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 13, 2026 - 10-KAnnual report for the fiscal year ended Dec 31, 2025
Mar 26, 2026 - 10-QQuarterly report for the period ended Sep 30, 2025
Nov 13, 2025 - 8-KDirector or officer change
Oct 29, 2025 - 8-KDirector or officer change
Oct 17, 2025 - 10-QQuarterly report for the period ended Jun 30, 2025
Aug 12, 2025